Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HeLa-T4 |
Human cervix carcinoma cell line susceptible to HIV-1 infection (Derivat of HeLa ) | Human | genital tract | cell line | suspension | plasmid | Metafectene | publication | D. Wilflingseder et al., J. Immunol., Jun 2007; 178: 7840 - 7848 | Link | |||
HEp-2 |
Human carcinoma cell line (HeLa contaminant) | ATCC CCL-23 | Human | unknown | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | H. Chi et al., Lin Chuang Er Bi Yan Hou Ke Za Zhi, Nov 2005; 19(21): 992-5 | ||
HEp-2 |
Human carcinoma cell line (HeLa contaminant) | ATCC CCL-23 | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | publication | R. S. Cruz Cosme et al., J. Virol., Apr 2009; 83: 2839 - 2850 | Link | ||
HEp-2 |
Human carcinoma cell line (HeLa contaminant) | ATCC CCL-23 | Human | unknown | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J.-S. Kim et al., Cancer Biol. & Ther., 2012, 13: 1307–1318, doi.org/10.4161/cbt.21788 | Link | |
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | sgRNA | CRISPR | Metafectene PRO | publication | R. Han et al., Scientific Reports, 2021, 11: 8626, doi.org/10.1038/s41598- | Link | |
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | CRISPR | Metafectene | publication | Y.-R. Kim et al., Exp. & Mol. Medicine, 2019, 51 :129, doi.org/10.1038/s12276-019-0340-1 | Link | |
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/sgRNA) | Metafectene PRO | publication | R. Han et al., Scientific Reports, 2021, 11: 8626, doi.org/10.1038/s41598- | Link | |
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | R. Xu et al., Onkolgy Letters, 2018, 16: 439-446, DOI: 10.3892/ol.2018.8672 | Link | ||
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | M. H. Kim et al., International Journal of Molecular Medicine, https://doi.org/10.3892/ijmm.2016.2835 | |||
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | W.-J. Park, Int. J. of Mol. Medicine, 2016, 37:613-622; DOI: 10.3892/ijmm.2016.2461 | Link | ||
Hep-G2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
hEPC |
Human endothelial progenitor cells | Human | other | primary cell | adherent | plasmid | Metafectene PRO | publication | G. Neumann, Dissertation, 2015, Georg-August-Universität zu Göttingen | Link | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ullio et al., J. Lipid Res., Jun 2012; 53: 1134 - 1143 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | F. Damiano et al., Biochim. et Biophys. Acta, 2015, 1849: 23-31; doi.org/10.1016/j.bbagrm.2014.10.004 | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | O. Pellerito et al., Mol. Pharmacol., May 2010; 77: 854 - 863 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | M.-H. Tai et al., Mol. Nutr. Food Res., 2014, 58: 2133-2145 DOI 10.1002/mnfr.201400366 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | miRNA | Metafectene PRO | publication | M. Vinod et al., Biochim. et Biophys. Acta, 2014, 1841: 827-835, doi.org/10.1016/j.bbalip.2014.02.006 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | miRNA | Metafectene PRO | publication | D.-W. Choi et al., Int. J. Mol. Med., 2021,48(6): 221, DOI: 10.3892/ijmm.2021.5054 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | V. C. Sladky et al., Developmental Cell, 2019, 52: 335–349, doi.org/10.1016/j.devcel.2019.12.016 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | F. Damiano et al., Biochem. J., 2013, 449: 543–553, doi:10.1042/BJ20120906 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link |